N-Oxalylglycine-Conjugated Hyaluronic Acid as a Macromolecular Prodrug for Therapeutic Angiogenesis
Hypoxia-inducible factor-1α (HIF-1α) initiates the cellular response to low oxygen levels, making it an attractive target for stimulating therapeutic angiogenesis. Several small molecules have been identified that stabilize HIF-1α and activate the angiogenic signaling pathway. However, achieving the...
Saved in:
Main Authors: | Andrew H. DeMaria, Jeoung Soo Lee, Ken Webb |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Gels |
Subjects: | |
Online Access: | https://www.mdpi.com/2310-2861/11/1/27 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pegylated NIR Fluorophore-Conjugated OBHSA Prodrug for ERα-Targeted Theranostics with Enhanced Imaging and Long-Term Retention
by: Xiaohua Wang, et al.
Published: (2025-01-01) -
Hipoksi ve Kanser
by: Sümeyye Aydogan Türkoğlu, et al.
Published: (2021-09-01) -
Methods for preliminary determination of pemetrexed in macromolecular drug-carrier systems
by: Ciekot Jarosław, et al.
Published: (2016-03-01) -
Mechanism of hyperbaric oxygen therapy downregulating H-type angiogenesis in subchondral bone of knee osteoarthritis through the PHD2/HIF-1α pathway
by: Jianjian Wang, et al.
Published: (2025-01-01) -
Prodrug-based bispecific antibodies for cancer therapy: advances and future directions
by: Zhijuan Ai, et al.
Published: (2025-01-01)